Hemorrhagic stroke.

Vascular and Critical Care Neurology, Massachusetts General Hospital, Boston, MA 02114, USA.
Neuroimaging Clinics of North America (Impact Factor: 1.2). 06/2005; 15(2):259-72, ix. DOI: 10.1016/j.nic.2005.05.003
Source: PubMed

ABSTRACT Neuroimaging by CT or MR imaging is necessary for the identification of hemorrhagic stroke and provides information about its cause. The appearance of intracranial hematoma (ICH) on CT and MR imaging evolves over time and must be understood to facilitate accurate diagnosis. The cause of ICH varies by location. New evidence suggests that MR imaging alone may be adequate to identify hemorrhagic stroke in the acute setting, and that MR imaging is superior to CT for identification of chronic microbleeds and hemorrhagic conversion of infarction.

  • Annals of Indian Academy of Neurology 01/2010; 13(3):223-4. · 0.93 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Interest in advanced neuroimaging is growing and is certain to continue; new and faster sequences, better image quality, higher magnetic fields, and improved models of diffusion, perfusion, and functional connectivity are in constant development. The purpose of this article is to highlight recent advances in neuroimaging from two aspects: (1) those advances directly benefited by increases in field strength (increased T1, signal-to-noise ratio, magnetic susceptibility-sensitivity, and chemical shift) and how the increased signal-to-noise ratio can be used to trade off for other advantages and (2) those advances made in response to attempts to try to reduce the inherent artifacts encountered at higher field strengths (eg, reducing specific radiofrequency absorption in tissue and magnetic susceptibility).
    Neurologic Clinics 03/2009; 27(1):1-19, xiii. · 1.34 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Intracranial hemorrhage is the third most common cause of stroke and involves the accumulation of blood within brain parenchyma or the surrounding meningeal spaces. Accurate identification of acute hemorrhage and correct characterization of the underlying pathology, such as tumor, vascular malformation, or infarction, is a critical step in planning appropriate therapy. Neuroimaging studies are required not only for diagnosis, but they also provide important information on the type of hemorrhage, etiology, and the pathophysiological process. Historically, computed tomography (CT) scan has been the diagnostic imaging study of choice; however, there is growing evidence suggesting that magnetic resonance imaging (MRI) is at least as sensitive as CT to detect intraparenchymal hemorrhages in the hyperacute setting, and actually superior to CT in the subacute and chronic settings. Unique MRI and CT characteristics differentiate secondary causes of hemorrhage from the more common hypertensive hemorrhage. Baseline and serial studies can be used to identify patients who might benefit from acute interventions. In addition, new imaging modalities, (such as magnetic resonance spectroscopy, diffusion tensor imaging, and 320-row CT) are promising research techniques that have the potential to enhance our understanding of the tissue injury and recovery after intracranial hemorrhages.
    Journal of the American Society for Experimental NeuroTherapeutics 01/2011; 8(1):28-38. · 5.38 Impact Factor


Available from